Short answer: telehealth is a delivery format, not a lower standard of care. A legitimate Women's Health provider verifies licensure in your state, takes a real history, discloses FDA-approved vs compounded sourcing, and sets a clear follow-up plan.
Whether you're looking into hormone therapy or sexual wellness care, the same underlying question applies: is this provider actually giving you real medical evaluation, or just a fast prescription? Telehealth is a delivery format, not a lower standard of care — a legitimate provider should offer the same core protections you'd expect in person.[2]Here's what that actually looks like.
Start With Who's Actually Treating You
Confirm who will diagnose and prescribe. The service should identify the clinician by name, credential, professional role, and the state or states where they're licensed or otherwise authorized to practice.[2]In most U.S. telehealth, the relevant location is wherever you're physically located during the visit — state licensure rules govern this, and the clinician generally needs authorization in your specific state. Interstate compacts and state-specific registration can apply, but they're not a universal national license.[1]You can independently verify credentials through your state medical board or FSMB's free DocInfo tool — these profiles commonly show license status and disciplinary history, and sometimes training, specialty certification, or sanctions.[3]A provider should confirm your location at every visit, explain what virtual care can and can't do, and tell you how to access urgent or in-person care when needed. A platform that won't identify its clinicians, won't explain their state authorization, or treats your location as irrelevant is a real red flag.[2]
What a Real Evaluation Looks Like — for Either Track
For HRT specifically, a legitimate diagnostic process starts with a meaningful history: menstrual and reproductive history, uterus status, hot flashes and night sweats, sleep, vaginal or urinary symptoms, sexual pain or low desire, current medications, medical and family history, and how symptoms are actually affecting your life.[4] Before prescribing systemic HRT, the clinician needs to review real contraindications — unexplained bleeding, prior estrogen-sensitive cancer, blood clots, stroke, heart disease, liver disease, or elevated clotting risk.[4]If you have a uterus and are considering systemic estrogen, the provider should explain exactly how endometrial protection will be handled — generally an adequate progestogen, unless you're using the specific combination product designed to avoid that requirement.[4]
For sexual wellness care, the evaluation should distinguish a real, diagnosable pattern of distressing low desire from situational or secondary causes — assessing relationship context, sexual pain or dryness, mood, sleep, medications, chronic conditions, menopause symptoms, and substance use. It should not simply route you toward a libido medication after a short intake form.[5]
Across either track, AMA ethics guidance is consistent: clinicians prescribing via telemedicine should verify your identity, confirm telehealth actually fits your situation, gather enough information for a sound decision, document the evaluation and prescription, and arrange in-person care when it's genuinely needed.[2]
Not everyone needs extensive labs.A credible service explains whether labs are actually clinically indicated, and why. For otherwise healthy women 45+ with typical menopause symptoms, diagnosis is often based on symptoms, age, and menstrual history rather than broad routine hormone panels — a provider shouldn't market every patient as needing expensive testing to "prove" menopause or "optimize" a standard dose.[6]Testing, an exam, imaging, or referral becomes appropriate when symptoms start unusually early, bleeding is abnormal, a medical risk is complex, the pattern is atypical, or another condition might explain what's happening. A good provider explains those limits rather than promising to handle every case remotely.[2]
Questions Worth Asking About the Actual Medication
Ask what's being prescribed, why it fits your specific symptoms, whether the use is FDA-approved or off-label, how it's administered, what risks and side effects matter, and how the plan changes if it doesn't help. A legitimate provider distinguishes a real treatment recommendation from a marketing claim.[2]"Bioidentical" specifically isn't a regulatory category — FDA-approved estradiol and micronized progesterone are bioidentical, and so are some compounded preparations. The word alone tells you nothing about whether a product is FDA-approved, safer, or more effective.[7]When a suitable FDA-approved option exists, ACOG recommends it over routine compounded bioidentical therapy — a legitimate provider discloses whether what they're prescribing is FDA-approved or compounded, and explains the specific patient reason for compounding if that's the recommendation.[7]Compounded drugs aren't FDA-approved and aren't reviewed before marketing for safety or effectiveness — poor compounding practices can create real quality problems, including contamination or inaccurate strength. That doesn't mean compounding never has a legitimate role; it means the regulatory status needs to be stated plainly.[8]
Pharmacy and Follow-Up Transparency
A provider should identify the dispensing or compounding pharmacy, clarify whether it's local or mail-order, explain fulfillment and shipping, state whether medication cost is included in the program fee, and give you a real way to ask a pharmacist or clinician questions.[2] Follow-up should be specified before you even enroll — reputable guidance calls for an early review around three months after starting to check benefit and tolerability, then periodic reassessment afterward, with earlier care for side effects, persistent symptoms, dose changes, or abnormal bleeding.[6] A reasonable program also tells you how to get copies of visit notes, lab results, prescriptions, and instructions, how to request refills, where to get urgent care, and how to transition to in-person or specialist care if needed.[2]
The Clear Red Flags
- Prescribing systemic HRT or sexual wellness medication without a real clinical review
- Concealing the clinician's identity or state authorization
- Promising the same regimen to every patient
- Using a saliva test or a single hormone number as the sole basis for treatment
- Calling a compounded medication "FDA-approved"
- Failing to disclose which pharmacy is dispensing your medication
- No real follow-up, cancellation, or escalation plan
These aren't nitpicks — they're inconsistent with the diagnostic and prescription-safety standards described in AMA telemedicine ethics guidance.[2]
What to Actually Compare Across Providers
A useful comparison checklist covers: clinician credentials and state availability, intake depth, lab and referral policies, medications offered and delivery routes, FDA-approved versus compounded disclosure, pharmacy fulfillment, monitoring cadence, transparent fees, insurance or cash-pay handling, cancellation terms, and access to real support. Those operational details tell you far more than a celebrity endorsement or a vague "optimization" claim ever will.[2]
The Bottom Line
Choose a provider for transparent, individualized care — not for whoever gets you a prescription fastest. Verify licensure, expect a real history and risk review, insist on clear medication sourcing and a real follow-up plan, and confirm the operational details directly since they're exactly the kind of thing that changes over time.
Worth comparing providers on both fronts — HRT evaluation quality and sexual wellness assessment depth — before deciding where to start, since the right fit depends on which track actually matches what you need.
Sources
- Getting Started With Licensure — Telehealth.HHS.gov, U.S. Department of Health and Human Services telehealth.hhs.gov
- Ethical Practice in Telemedicine — American Medical Association Code of Medical Ethics code-medical-ethics.ama-assn.org
- Information for Consumers — Federation of State Medical Boards fsmb.org
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society — The Menopause Society / Menopause menopause.org
- International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women — Mayo Clinic Proceedings mayoclinicproceedings.org
- Menopause: Identification and Management (NG23), Recommendations — National Institute for Health and Care Excellence nice.org.uk
- Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6 — American College of Obstetricians and Gynecologists acog.org
- Consumer and Health Care Professional Information — U.S. Food and Drug Administration fda.gov
Frequently Asked Questions
Does my Women's Health telehealth provider need to be licensed in my state?
Yes — telehealth is generally considered to occur where you're physically located, and the clinician needs to be licensed or authorized there.[1]
What's a major red flag for an illegitimate provider?
Prescribing HRT or sexual wellness medication without a real clinical history and risk review, or refusing to identify the prescribing clinician and their license.[2]
Should a provider tell me if my medication is compounded?
Yes — a credible provider clearly discloses whether medication is FDA-approved or compounded, and explains the specific reason for recommending compounding if that's the plan.[7]
What should follow-up care actually look like?
An early check-in around three months after starting to assess benefit and tolerability, then periodic reassessment — with earlier contact for side effects, persistent symptoms, or abnormal bleeding.[6]